anacor.com
Collaborations | Anacor Pharmaceuticals
http://www.anacor.com/partnering.php
Our Key Neglected Diseases Initiatives:. In recent years, a number of foundations and governments have created public-private partnerships to fund promising technologies that may result in new drugs for neglected diseases. Below is an overview of our key initiatives in this area:. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. 2016 Anacor Pharmaceuticals, Inc.
anacor.com
Careers | Anacor Pharmaceuticals
http://www.anacor.com/careers_overview.php
At Anacor, we pride ourselves on the progress weve made in building a strong pipeline based on our novel boron chemistry platform. Our future success is based on our ability to recruit and retain talented individuals. Join the Anacor Team. Candidates should submit their resume for posted open positions via email to jobs@anacor.com. Stating the position title in the subject line: jobs@anacor.com. No agency or recruiter contacts please. Anacor is proud to be an Equal Opportunity Employer. Paul L. Berns.
anacor.com
Research and Development | Anacor Pharmaceuticals
http://www.anacor.com/pipeline_overview.php
Next generation PDE-4 inhibitor. Lilly licensed this compound from us in December 2012 for the potential treatment of an animal health indication and is responsible for all further development and commercialization. We are eligible to receive additional development and regulatory milestones, as well as tiered royalties from the high single digits to in-the-tens on any future sales. Is a registered trademark of Eli Lilly and Company. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Paul L. Berns.
anacor.com
Kerydin® | Anacor Pharmaceuticals
http://www.anacor.com/an2690.php
Tavaborole) topical solution, 5% has received FDA approval. Please click here for prescribing information. To report an Adverse Event or Product Complaint. Associated with Kerydin, please call 1-844-4ANACOR (1-844-426-2267) and select option 1 or email drugsafety@anacor.com. To request Medical or Drug Information. About Kerydin, please call 1-855-260-3479 or email FougeraPCC@druginfo.com. To reach Customer Service. For Kerydin, please call 1-800-525-8747 or email customerservice@pharmaderm.com.
anacor.com
Neglected Diseases | Parasitic & Bacterial Diseases | Anacor Pharmaceuticals
http://www.anacor.com/neglected_diseases.php
Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. 2016 Anacor Pharmaceuticals, Inc.
anacor.com
Careers | Anacor Pharmaceuticals
http://www.anacor.com/open_careers.php
At Anacor, we pride ourselves on the progress weve made in building a strong pipeline based on our novel boron chemistry platform. Our future success is based on our ability to recruit and retain talented individuals. Join the Anacor Team. Candidates should submit their resume for posted open positions via email to jobs@anacor.com. Stating the position title in the subject line: jobs@anacor.com. No agency or recruiter contacts please. Anacor is proud to be an Equal Opportunity Employer. Paul L. Berns.
anacor.com
Research and Development | Anacor Pharmaceuticals
http://www.anacor.com/clinical_trials.php
Next generation PDE-4 inhibitor. Lilly licensed this compound from us in December 2012 for the potential treatment of an animal health indication and is responsible for all further development and commercialization. We are eligible to receive additional development and regulatory milestones, as well as tiered royalties from the high single digits to in-the-tens on any future sales. Is a registered trademark of Eli Lilly and Company. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Paul L. Berns.
anacor.com
The Management of Anacor Pharmaceuticals
http://www.anacor.com/anacor_management.php
Paul L. Berns. President, Chief Executive Officer and Chairman of the Board. Executive Vice President and Chief Financial Officer. Executive Vice President and Chief Commercial Officer. Ryan T. Sullivan. Executive Vice President and General Counsel. Lee T Zane, M.D. Senior Vice President and Chief Medical Officer. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. Paul L. Berns.
anacor.com
Animal Health | Anacor Pharmaceuticals
http://www.anacor.com/animal_health.php
Our Collaboration with Eli Lilly and Company. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. 2016 Anacor Pharmaceuticals, Inc.
anacor.com
Collaborations | Anacor Pharmaceuticals
http://www.anacor.com/strategic_alliances.php
Our Key Neglected Diseases Initiatives:. In recent years, a number of foundations and governments have created public-private partnerships to fund promising technologies that may result in new drugs for neglected diseases. Below is an overview of our key initiatives in this area:. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. Medical Education Grants and Healthcare Charitable Contributions. Paul L. Berns. Ryan T. Sullivan. Lee T Zane, M.D. 2016 Anacor Pharmaceuticals, Inc.
SOCIAL ENGAGEMENT